Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[11] Myelodysplastic syndromes: molecular markers
Wainscoat, J. S.
LEUKEMIA RESEARCH, 2007, 31 : S13 - S13
[12] Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
Acha, Pamela
Mallo, Mar
Sole, Francesc
CANCERS, 2022, 14 (22)
[13] Platelet mass has prognostic value in patients with myelodysplastic syndromes
Bowles, Kristian M.
Warner, Brian A.
Baglin, Trevor P.
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (02) : 198 - 200
[14] Evaluation of the Selected Parameters of Bone Marrow Cell Subpopulations by Flow Cytometry and Analysis of Their Diagnostic and Prognostic Value in Patients with Myelodysplastic Syndromes
Majcherek, Maciej
Kiernicka-Parulska, Jolanta
Mierzwa, Anna
Bara, Marta
Komarnicki, Mieczyslaw
Lewandowski, Krzysztof
Czyz, Anna
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S338 - S338
[15] Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes
Kuendgen, Andrea
Seidler, Jenny
Lauseker, Michael
Haferlach, Torsten
Schnittger, Susanne
Kohlmann, Alexander
Hildebrandt, Barbara
Mueller-Thomas, Catharina
Betz, Beate
Haas, Rainer
Gattermann, Norbert
Royer-Pokora, Brigitte
Goetze, Katharina
Germing, Ulrich
BLOOD, 2013, 122 (21)
[16] Diagnostic and Prognostic Utility of Plasma microRNA Signatures in Patients with Myelodysplastic Syndromes
Loghavi, S.
Bueso-Ramos, C. E.
Maiti, S. N.
Hu, S.
Calin, G. A.
Garcia-Manero, G.
Kantarjian, H. M.
Medeiros, J.
Cooper, L.
Zuo, Z.
MODERN PATHOLOGY, 2014, 27 : 359A - 359A
[17] Diagnostic and Prognostic Utility of Plasma microRNA Signatures in Patients with Myelodysplastic Syndromes
Loghavi, S.
Bueso-Ramos, C. E.
Maiti, S. N.
Hu, S.
Calin, G. A.
Garcia-Manero, G.
Kantarjian, H. M.
Medeiros, J.
Cooper, L.
Zuo, Z.
LABORATORY INVESTIGATION, 2014, 94 : 359A - 359A
[18] Evaluation of cellular proliferation markers in patients with myelodysplastic syndromes.
Ismail, SO
Mutema, G
Perrotta, G
Hornback, B
Wibowo, A
Mazzella, F
KowalVern, A
Schumacher, HR
BLOOD, 1997, 90 (10) : 4040 - 4040
[19] Classification and Prognostic Evaluation of Myelodysplastic Syndromes
Cazzola, Mario
Della Porta, Matteo G.
Travaglino, Erica
Malcovati, Luca
SEMINARS IN ONCOLOGY, 2011, 38 (05) : 627 - 634
[20] Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes
Kuendgen, A.
Gattermann, N.
Germing, U.
LEUKEMIA, 2009, 23 (01) : 182 - 184

← 1 2 3 4 5 →